LORUSSO, LOREDANA
 Distribuzione geografica
Continente #
NA - Nord America 1.321
EU - Europa 1.023
AS - Asia 182
AF - Africa 51
SA - Sud America 13
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.593
Nazione #
US - Stati Uniti d'America 1.306
IT - Italia 336
DE - Germania 265
SE - Svezia 169
GB - Regno Unito 85
CN - Cina 75
BG - Bulgaria 69
AT - Austria 59
SG - Singapore 38
CI - Costa d'Avorio 26
VN - Vietnam 24
SN - Senegal 21
IN - India 16
CA - Canada 15
RU - Federazione Russa 12
FI - Finlandia 8
JP - Giappone 7
TR - Turchia 7
CL - Cile 6
CH - Svizzera 5
UA - Ucraina 5
HK - Hong Kong 4
PH - Filippine 4
AU - Australia 2
EG - Egitto 2
IL - Israele 2
NL - Olanda 2
PL - Polonia 2
UY - Uruguay 2
VE - Venezuela 2
ZA - Sudafrica 2
A1 - Anonimo 1
AR - Argentina 1
BR - Brasile 1
CO - Colombia 1
DK - Danimarca 1
FR - Francia 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 2.593
Città #
Chandler 174
Milan 170
Fairfield 150
Woodbridge 130
Ashburn 90
Houston 85
Seattle 85
Sofia 69
Vienna 58
Cambridge 56
New York 56
Wilmington 56
Ann Arbor 52
Princeton 36
London 31
Florence 30
Abidjan 26
Beijing 26
Lawrence 25
Dearborn 22
Bremen 21
Dakar 21
Medford 21
Frankfurt am Main 17
Pisa 13
Rome 13
Dong Ket 12
Redwood City 12
Ottawa 11
San Diego 11
Des Moines 10
Serra 10
Washington 9
Redmond 8
Lancaster 7
Nanjing 7
Izmir 6
Los Angeles 6
Nanchang 6
Salt Lake City 6
Scandicci 6
Chiesina Uzzanese 5
Hefei 5
Singapore 5
Bern 4
Hong Kong 4
Phoenix 4
Santiago 4
Shenyang 4
Bangalore 3
Boulder 3
Cleveland 3
Hatfield 3
Jiaxing 3
Shanghai 3
Tianjin 3
Toronto 3
Vicopisano 3
Angri 2
Bientina 2
Epsom 2
Hyderabad 2
Irsina 2
Jinan 2
Johannesburg 2
Konandai 2
Kunming 2
Makati City 2
Manila 2
Munich 2
Norwalk 2
Ogden 2
Remington 2
San Francisco 2
Scandiano 2
St Albans 2
Stuttgart 2
Zhengzhou 2
Aguada 1
Amsterdam 1
Ardea 1
Azor 1
Bergamo 1
Bogotá 1
Bratislava 1
Busto Arsizio 1
Changsha 1
Chengdu 1
Copenhagen 1
Council Bluffs 1
Dublin 1
Earlsfield 1
Edinburgh 1
El Segundo 1
Genova 1
Guangzhou 1
Gurgaon 1
Hebei 1
Indiana 1
Indianapolis 1
Totale 1.784
Nome #
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 160
Targeted Therapy in Thyroid Cancer: State of the Art 149
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 140
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 131
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 128
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer 125
null 122
Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing 121
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 120
Il carcinoma tiroideo: nuove prospettive terapeutiche. 119
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 119
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 113
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 108
Less than 2% of the low- and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan 95
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center 91
Carcinoma tiroideo e gravidanza. 84
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH 77
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 75
null 70
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 64
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST 62
null 54
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 52
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 46
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates 44
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 43
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 42
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 41
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer 33
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features 16
Risultati dello studio di fase III, randomizzato, controllato, in doppio cieco, Sorafenib vs Placebo nel trattamento del carcinoma differenziato della tiroide (CDT) localmente avanzato o metastatico, refrattario al 131I, in progressione. 10
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib 7
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 5
Totale 2.666
Categoria #
all - tutte 7.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019120 0 0 0 0 0 0 0 0 0 33 49 38
2019/2020559 49 38 39 39 57 65 59 39 46 47 68 13
2020/2021242 39 11 24 10 14 31 10 12 21 16 21 33
2021/2022323 19 6 2 13 64 49 9 16 26 19 22 78
2022/2023647 74 106 50 63 60 75 6 36 106 14 48 9
2023/2024448 58 71 78 47 67 87 19 9 5 7 0 0
Totale 2.666